<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-19212</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0078887</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories>
<title-group>
<article-title>Spontaneous NF-κB Activation by Autocrine TNFα Signaling: A Computational Analysis</article-title>
<alt-title alt-title-type="running-head">Spontaneous NF-κB System Activation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pękalski</surname><given-names>Jakub</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zuk</surname><given-names>Pawel J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kochańczyk</surname><given-names>Marek</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Junkin</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kellogg</surname><given-names>Ryan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tay</surname><given-names>Savaş</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>Tomasz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, Poland</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Institute of Theoretical Physics, Faculty of Physics, University of Warsaw, Warsaw, Poland</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>Department of Statistics, Rice University, Houston, Texas, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Garcia-Ojalvo</surname><given-names>Jordi</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universitat Politecnica de Catalunya, Spain</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">tlipnia@ippt.gov.pl</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: ST TL. Performed the experiments: MJ RK. Analyzed the data: JP MJ RK. Wrote the paper: TL. Designed study: TL. Performed mathematical and numerical analysis: JP MK. Wrote the numerical codes: PJZ MK JP.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>11</day><month>11</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>11</issue>
<elocation-id>e78887</elocation-id>
<history>
<date date-type="received"><day>9</day><month>5</month><year>2013</year></date>
<date date-type="accepted"><day>16</day><month>9</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Pękalski et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>NF-κB is a key transcription factor that regulates innate immune response. Its activity is tightly controlled by numerous feedback loops, including two negative loops mediated by NF-κB inducible inhibitors, IκBα and A20, which assure oscillatory responses, and by positive feedback loops arising due to the paracrine and autocrine regulation via TNFα, IL-1 and other cytokines. We study the NF-κB system of interlinked negative and positive feedback loops, combining bifurcation analysis of the deterministic approximation with stochastic numerical modeling. Positive feedback assures the existence of limit cycle oscillations in unstimulated wild-type cells and introduces bistability in A20-deficient cells. We demonstrated that cells of significant autocrine potential, i.e., cells characterized by high secretion of TNFα and its receptor TNFR1, may exhibit sustained cytoplasmic–nuclear NF-κB oscillations which start spontaneously due to stochastic fluctuations. In A20-deficient cells even a small TNFα expression rate qualitatively influences system kinetics, leading to long-lasting NF-κB activation in response to a short-pulsed TNFα stimulation. As a consequence, cells with impaired A20 expression or increased TNFα secretion rate are expected to have elevated NF-κB activity even in the absence of stimulation. This may lead to chronic inflammation and promote cancer due to the persistent activation of antiapoptotic genes induced by NF-κB. There is growing evidence that A20 mutations correlate with several types of lymphomas and elevated TNFα secretion is characteristic of many cancers. Interestingly, A20 loss or dysfunction also leaves the organism vulnerable to septic shock and massive apoptosis triggered by the uncontrolled TNFα secretion, which at high levels overcomes the antiapoptotic action of NF-κB. It is thus tempting to speculate that some cancers of deregulated NF-κB signaling may be prone to the pathogen-induced apoptosis.</p>
</abstract>
<funding-group><funding-statement>Foundation for Polish Science grant # Team 2009-3/6; Polish National Science Centre grant # 2011/03/B/NZ2/00281; Swiss National Science Foundation grant # 205321_141299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="14"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<sec id="s1a">
<title>NF-κB Regulatory System</title>
<p>Innate immunity forms the first line of defense against pathogens. In the first phase, cells detect pathogens with their membrane and cytoplasmic receptors. This leads to the activation of transcription factors from the NF-κB, IRF and AP-1 families. These factors jointly regulate the activity of several hundred genes responsible for inflammation, antiviral protection, proliferation and apoptosis. In particular, they induce the production of pro-inflammatory cytokines like IL-1, TNFα, as well as IFN-α and IFN-ß. Secretion of these cytokines leads to the second phase of the cellular innate immune response in cells that have not yet encountered the pathogen. The cytokine-activated cells may themselves produce and secrete the same cytokines leading to the spread of paracrine signaling <xref ref-type="bibr" rid="pone.0078887-Yde1">[1]</xref>, <xref ref-type="bibr" rid="pone.0078887-Rand1">[2]</xref> or to augmenting and stabilizing signaling in the secreting cells via autocrine regulation <xref ref-type="bibr" rid="pone.0078887-Covert1">[3]</xref>, <xref ref-type="bibr" rid="pone.0078887-Lee1">[4]</xref>. In the current study, the focus is on the analysis of TNFα autocrine regulation in the NF-κB pathway.</p>
<p>NF-κB regulates numerous genes important for pathogen- or cytokine-induced inflammation, immune response, cell proliferation and survival (reviewed in <xref ref-type="bibr" rid="pone.0078887-Brasier1">[5]</xref>, <xref ref-type="bibr" rid="pone.0078887-Hoffmann1">[6]</xref>). Nuclear activity of NF-κB is tightly controlled by negative feedback loops mediated by NF-κB-responsive proteins: IκBα <xref ref-type="bibr" rid="pone.0078887-Brown1">[7]</xref>–<xref ref-type="bibr" rid="pone.0078887-Cho1">[9]</xref>, IκBϵ <xref ref-type="bibr" rid="pone.0078887-Hoffmann2">[8]</xref>, <xref ref-type="bibr" rid="pone.0078887-Whiteside1">[10]</xref>, <xref ref-type="bibr" rid="pone.0078887-Kearns1">[11]</xref> and A20 <xref ref-type="bibr" rid="pone.0078887-Krikos1">[12]</xref>–<xref ref-type="bibr" rid="pone.0078887-Lee2">[14]</xref>. These negative feedback loops lead to oscillatory responses, in which NF-κB circulates between the cytoplasm and nucleus with the period of about 100 min <xref ref-type="bibr" rid="pone.0078887-Hoffmann2">[8]</xref>. The primary inhibitors, IκBα and IκB, directly bind to NF-κB, inhibit its transcriptional activity and transport it back to the cytoplasm. Interestingly, expression of IκBϵ is delayed with respect to IκBα <xref ref-type="bibr" rid="pone.0078887-Kearns1">[11]</xref>, which increases desynchronization of cells and leads to damping of oscillations observed at the population level, resulting in robust tissue responses <xref ref-type="bibr" rid="pone.0078887-Paszek1">[15]</xref>. A20 mediates the outer negative feedback loop by attenuating the catalytic activity of the IKK complex (consisting of IKKγ, also called NEMO, IKKα and IKKß). In A20-deficient cells the IKK activity remains at a high level preventing the accumulation of inhibitors IκBα and IκBϵ <xref ref-type="bibr" rid="pone.0078887-Lee2">[14]</xref>. This leads, in turn, to the elevated NF-κB transcriptional activity and causes chronic inflammation. There are at least two levels of A20-mediated regulation of IKK complex activity: (1) A20 directly interacts with the IKK complex reducing its catalytic activity <xref ref-type="bibr" rid="pone.0078887-Zhang1">[16]</xref>–<xref ref-type="bibr" rid="pone.0078887-Skaug1">[18]</xref> and (2) A20 primes TNF receptor interacting protein (RIP) for degradation, and thus attenuates TNF receptor downstream signaling <xref ref-type="bibr" rid="pone.0078887-Wertz1">[19]</xref>.</p>
<p>Regarding the direct regulation mode, A20 binds to IKKγ and speeds up further phosphorylation of active IKKß kinase into the inactive form <xref ref-type="bibr" rid="pone.0078887-Zhang1">[16]</xref>, <xref ref-type="bibr" rid="pone.0078887-Delhase1">[20]</xref>. (IKKß activation proceeds via phosphorylation at Ser-177 and Ser-181, but further phosphorylation at the C-terminal serine cluster inhibits its catalytic activity <xref ref-type="bibr" rid="pone.0078887-Delhase1">[20]</xref>.) Later, it was found that A20 and ABIN-1 bind to the IKK complex, and A20 inhibits activation of NF-κB by de-ubiquitination of IKKγ <xref ref-type="bibr" rid="pone.0078887-Mauro1">[17]</xref>, reviewed recently in <xref ref-type="bibr" rid="pone.0078887-Chen1">[21]</xref>. (Lys-63-linked ubiquitination of IKKγ is an important step for the activation of IKK and NF-κB following various stimuli, including TNFα <xref ref-type="bibr" rid="pone.0078887-Zhou1">[22]</xref>.) Interestingly, A20 itself is a putative substrate of IKKß, which phosphorylates A20 on Ser-381, thereby increasing its ability to downregulate NF-κB in response to multiple stimuli <xref ref-type="bibr" rid="pone.0078887-Hutti1">[23]</xref>. Recently, Skaug et al. reported a direct non-catalytic mechanism of IKK inhibition by A20 showing that overexpressed A20 impaired IKK activation without reducing RIP1 ubiquitination <xref ref-type="bibr" rid="pone.0078887-Skaug1">[18]</xref>.</p>
<p>Regarding the indirect IKK regulation mode, A20 acts as a ubiquitin editing protein: it removes Lys-63-linked ubiquitin chains from RIP and then functions as a ubiquitin ligase by polyubiquitinating RIP with Lys-48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation, and thus attenuating TNFR1 receptor signaling <xref ref-type="bibr" rid="pone.0078887-Wertz1">[19]</xref>, reviewed in <xref ref-type="bibr" rid="pone.0078887-Harhaj1">[24]</xref>, <xref ref-type="bibr" rid="pone.0078887-Harhaj2">[25]</xref>. The modeling studies showed distinctive roles of these two, direct and indirect, modes of regulation <xref ref-type="bibr" rid="pone.0078887-Lipniacki1">[26]</xref>, <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>. The direct mode allows for the termination (or strong reduction) of IKK activity after A20 is synthesized (which takes about 1 hour) <xref ref-type="bibr" rid="pone.0078887-Lipniacki1">[26]</xref>, while the second mode renders cells less sensitive to subsequent pulses of TNFα, if these pulses are separated by a short timespan <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>.</p>
<p>Later studies showed that the role of A20 goes beyond the control of NF-κB and that A20 is a general inhibitor in innate immune signaling; it protects cells from chronic inflammation, endotoxic shock and plays a role of tumor suppressor <xref ref-type="bibr" rid="pone.0078887-Boone1">[28]</xref>, <xref ref-type="bibr" rid="pone.0078887-Honma1">[29]</xref>. In particular, A20 inhibits IRF3/IRF7 signaling <xref ref-type="bibr" rid="pone.0078887-Lin1">[30]</xref>, <xref ref-type="bibr" rid="pone.0078887-Zhao1">[31]</xref>. Similarly as for the NF-κB pathway, it acts upstream of the TBK1–IKKϵ–IKKγ complex regulating negatively retinoic acid-inducible gene I protein (RIG-I) <xref ref-type="bibr" rid="pone.0078887-Lin2">[32]</xref>, and potentially may act at the level of this complex by binding to IKKγ <xref ref-type="bibr" rid="pone.0078887-Zhao1">[31]</xref>.</p>
<p>As said, the negative feedback loops involving IκBα and A20 lead to oscillatory responses. These oscillations appear damped when analyzed at the population level, but single cell experiments by Nelson et al. on SK-N-AS cells and Tay et al. on 3T3 cells demonstrated that oscillations persist at least up to 10 hours <xref ref-type="bibr" rid="pone.0078887-Nelson1">[33]</xref>, <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>. Discrepancy between population- and single cell-based observations can be explained by the progressing desynchronization of cells in the population <xref ref-type="bibr" rid="pone.0078887-Lipniacki3">[35]</xref>, <xref ref-type="bibr" rid="pone.0078887-Lipniacki4">[36]</xref>, although the controversy about reconciling single cell and population data still exists <xref ref-type="bibr" rid="pone.0078887-Barken1">[37]</xref>. The major objection towards single cell experiments is that the additional gene copies coding for fluorescently tagged NF-κB may alter dynamics of the whole system. However, both experimental <xref ref-type="bibr" rid="pone.0078887-Nelson2">[38]</xref> and modeling studies <xref ref-type="bibr" rid="pone.0078887-Hat1">[39]</xref> show that the number of NF-κB gene copies or its expression level influences only the amplitude but not the period of oscillations. Moreover, in our recent experiment <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>, the expression of NF-κB remained practically unchanged due to the knockout of endogenous RelA, yet the oscillatory pattern was still clearly visible for 10 ng/ml TNFα dose.</p>
</sec><sec id="s1b">
<title>TNFα Autocrine and Paracrine Signaling</title>
<p>TNFα affects growth, differentiation and function of cells of many types, and is a major mediator of inflammatory immune responses <xref ref-type="bibr" rid="pone.0078887-Beutler1">[40]</xref>, <xref ref-type="bibr" rid="pone.0078887-Aggarwal1">[41]</xref>. It is considered as a key mediator of the septic shock syndrome induced by either LPS or bacterial superantigens <xref ref-type="bibr" rid="pone.0078887-Xaus1">[42]</xref>, <xref ref-type="bibr" rid="pone.0078887-Tracey1">[43]</xref>. The potent activating abilities of TNFα are transmitted by 2 distinct cell-surface receptors: TNFR1 and TNFR2; the first one binds TNFα molecules with higher affinity <xref ref-type="bibr" rid="pone-0078887-Grell1">[44]</xref> and is considered responsible for the most of TNFα-induced signaling <xref ref-type="bibr" rid="pone.0078887-Beg1">[45]</xref>. It is established that binding of TNFα initiates protein–protein interactions between TNFR1 and the TNFR-associated death domain protein (TRADD). TRADD in turn recruits receptor-interacting protein (RIP) and TRAF2 for NF-κB and survival signals <xref ref-type="bibr" rid="pone.0078887-Kelliher1">[46]</xref>, <xref ref-type="bibr" rid="pone.0078887-Hsu1">[47]</xref>.</p>
<p>The TNFα autocrine and paracrine signaling arises since TNFα-inducible NF-κB serve itself as a primary transcription factor for TNFα. Over twenty years ago Collart et al. showed that TNFα promoter contains four κB motifs that can bind constitutive and inducible forms of NF-κB <xref ref-type="bibr" rid="pone.0078887-Collart1">[48]</xref>. Further analysis of κB motives in TNFα promoter revealed that two sites, κB2 and κB2a, play a primary role in TNFα regulation by NF-κB in response to LPS stimulation in human monocytes <xref ref-type="bibr" rid="pone.0078887-Udalova1">[49]</xref>.</p>
<p>The autocrine regulation was observed in various cell lines and tissues: first, Wu et al. showed that TNFα functions as autocrine and paracrine growth factor in ovarian cancer <xref ref-type="bibr" rid="pone.0078887-Wu1">[50]</xref>. Coward et al. and Guergnon et al. demonstrated that TNFα induces TNFα synthesis via NF-κB activation in human lung mast cells and B cells <xref ref-type="bibr" rid="pone.0078887-Coward1">[51]</xref>, <xref ref-type="bibr" rid="pone-0078887-Guergnon1">[52]</xref>; Nadeau and Rivest found that <italic>in vivo</italic> TNFα injection induced TNFα mRNA expression in microglia and astrocytes <xref ref-type="bibr" rid="pone.0078887-Nadeau1">[53]</xref>, and later Kuno et al. showed that the activation of microglia by LPS is partially mediated by microglia-derived TNFα, confirming the existence of a positive feedback loop <xref ref-type="bibr" rid="pone.0078887-Kuno1">[54]</xref>. Hu et al. demonstrated that autocrine TNFα signalling (via NF-κB) mediates endoplasmic reticulum stress-induced cell death <xref ref-type="bibr" rid="pone.0078887-Hu1">[55]</xref>. Recently, Rushworth et al. reported the autocrine TNF signaling (via NF-κB) in monocytes: TNF stimulation leads to sustained production of TNF mRNA for 48 hours; the NF-κB inhibition suppresses the TNF autocrine regulation <xref ref-type="bibr" rid="pone.0078887-Rushworth1">[56]</xref>. Although observed in many cell lines, strength of the autocrine and paracrine TNFα signaling is cell line-specific. Cells can be characterized by their autocrine potential based on their ability to secrete TNFα and by their sensitivity to TNFα stimulation controlled primarily by the TNFR1 level.</p>
<p>Autocrine TNFα signaling may start spontaneously or in response to numerous stimuli, including TNFα itself, other cytokines, or LPS. The spontaneous activation of the NF-κB signaling pathway was observed in isolated normal glomeruli <xref ref-type="bibr" rid="pone.0078887-Hayakawa1">[57]</xref>. The data suggested that NF-κB was spontaneously activated in explanted glomeruli via autocrine/paracrine factors including TNFα.</p>
<p>Although NF-κB serves itself as a primary transcription factor for TNFα, there are other factors and mechanisms which control TNFα mRNA synthesis, transcript stability, translation and TNFα protein secretion. TNFα gene regulation in activated T cells involves AP-1 transcription factors ATF-2 and c-Jun which cooperate with NFATp <xref ref-type="bibr" rid="pone.0078887-Tsai1">[58]</xref>. In macrophages, c-Jun and C/EBPß transcriptionally activate TNFα, however regulation by NF-κB was found stronger and independent of these factors <xref ref-type="bibr" rid="pone.0078887-Liu1">[59]</xref>. Covert and colleagues <xref ref-type="bibr" rid="pone.0078887-Covert1">[3]</xref>, <xref ref-type="bibr" rid="pone.0078887-Lee1">[4]</xref> proposed that the LPS-induced TNFα secretion is mediated by TRIF-dependent activation of IRF3. Stability of TNFα mRNA is signal-dependent; Deleault et al. demonstrated that simultaneous activation of both ERK and p38 inhibit tristetraprolin and stabilize TNFα mRNA <xref ref-type="bibr" rid="pone.0078887-Deleault1">[60]</xref>. Massive TNFα protein production requires ERK and p38 atop of NF-κB in mice with constitutively active IKKß <xref ref-type="bibr" rid="pone-0078887-Guma1">[61]</xref>. In LPS-stimulated murine dendritic cells, MK2, effector kinase of p38 promotes TNFα translation <xref ref-type="bibr" rid="pone-0078887-Gais1">[62]</xref>. Interestingly, in articular chondrocytes and skeletal muscles, TNFα stimulates the activation of three subclasses of MAPKs: ERKs, p38, and JNKs <xref ref-type="bibr" rid="pone.0078887-Liacini1">[63]</xref>, <xref ref-type="bibr" rid="pone.0078887-Li1">[64]</xref>. This opens the possibility that in some cells TNFα autocrine regulation involves both NF-κB-induced TNFα transcription and MAPK pathway-driven TNFα translation.</p>
<p>Majority of mechanisms which increase TNFα mRNA stability and translation, discussed above, are induced by the LPS stimulation, which strongly activates MAPK pathways as well as NF-κB via MyD88 (early phase) and TRIF-dependent pathways (late phase), reviewed in <xref ref-type="bibr" rid="pone.0078887-Kawai1">[65]</xref>, <xref ref-type="bibr" rid="pone.0078887-Kawai2">[66]</xref>. Xaus et al. showed that LPS induces apoptosis in macrophages via autocrine TNFα production, and this mechanism is suppressed in TNFR1-deficient mice <xref ref-type="bibr" rid="pone.0078887-Xaus1">[42]</xref>. Hao and Baltimore found that TNFα mRNA degradation is several-fold lower when TNFα is produced in response to LPS when compared to TNFα stimulation <xref ref-type="bibr" rid="pone.0078887-Hao1">[67]</xref>. This explains why the LPS stimulation leads to the massive secretion of TNFα, which in turn may trigger autocrine signaling, leading to prolonged oscillations of NF-κB, observed recently in a fraction of LPS-stimulated cells <xref ref-type="bibr" rid="pone-0078887-Gutschow1">[68]</xref>.</p>
<p>Finally, we should mention that there exist other cytokines, in particular IL-1, which are NF-κB-responsive <xref ref-type="bibr" rid="pone.0078887-Hiscott1">[69]</xref>, and which in turn may activate NF-κB <xref ref-type="bibr" rid="pone.0078887-Schooley1">[70]</xref>. For the sake of simplicity and clarity, we neglect this positive feedback loop in the current study.</p>
</sec></sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<p>The modeling studies of NF-κB system started in 2002, by the study of oscillations of NF-κB–IκBα feedback loop (damped by the presence of IκBϵ and IκBß isoforms) by Hoffmann, Levchenko and colleagues <xref ref-type="bibr" rid="pone.0078887-Hoffmann2">[8]</xref>, followed by Lipniacki et al. study introducing A20 regulatory loop <xref ref-type="bibr" rid="pone.0078887-Lipniacki1">[26]</xref>, reviewed in <xref ref-type="bibr" rid="pone.0078887-Lipniacki4">[36]</xref>, <xref ref-type="bibr" rid="pone.0078887-Cheong1">[71]</xref>. The considered model is based on our earlier studies <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>, <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>. The key modification is the inclusion of autocrine regulation via TNFα which leads to the positive feedback loop and qualitatively changes dynamics of cells characterized by sizable TNFα synthesis. For completeness of the current study, we briefly review the structure of the model. The detailed description of the mathematical methods and the model, including the list of reactions and corresponding ordinary differential equations (ODEs), can be found in <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref>. The model involves seven proteins: NF-κB, its inducible inhibitors IκBα and A20, signal transduction kinases IKK and IKKK, cytokine TNFα and its receptor TNFR1 (<xref ref-type="fig" rid="pone-0078887-g001">Fig. 1</xref>). The model is two-compartmental and the translocations of NF-κB, IκBα and their complex between the cytoplasmic and nuclear compartments are considered. However, in contrast to recent studies by Terry and Chaplain <xref ref-type="bibr" rid="pone.0078887-Terry1">[72]</xref>, we do not account for spatial gradients (leading to the diffusion and transport terms) within these two compartments. Total levels of NF-κB, IKK and IKKK are assumed constant, without accounting for their production and degradation explicitly. In the case of IκBα, A20 and TNFα, the processes of mRNA transcription and protein translation are explicitly present in the model. The activation of corresponding genes follows NF-κB binding, while gene inactivation follows the NF-κB removal via IκBα binding.</p>
<fig id="pone-0078887-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g001</object-id><label>Figure 1</label><caption>
<title>Schematic of the NF-κB model.</title>
<p>Solid arrow-headed lines denote transitions; dashed lines denote influence: positive for circle-headed lines, negative for hammer-headed lines.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g001" position="float" xlink:type="simple"/></fig><sec id="s2a">
<title>A20 And Iκbα Negative Feedback Loops</title>
<p>Nuclear NF-κB activity is controlled by two interlinked negative feedback loops, one mediated by IκB proteins: IκBα and IκB, the other mediated by A20 (<xref ref-type="fig" rid="pone-0078887-g001">Fig. 1</xref>). The inhibitors IκBα and IκB bind NF-κB and sequester it in the cytoplasm. Upon the signal mediated by the kinases IKKK and IKK, IκBα is phosphorylated and rapidly degraded. IκB is also phosphorylated and degraded, although its degradation (and further resynthesis) is delayed by about 45 min with respect to IκBα. Free NF-κB translocates to the nucleus and triggers transcription of its inhibitors, IκBα, IκB and A20. Synthesized IκBα and IκB translocate to the nucleus, bind NF-κB and convey it back to the cytoplasm. IκB is several fold less abundant than the primary inhibitor IκBα, and as demonstrated by experimental and computational studies the main impact of IκB on the system dynamic is in desynchronizing cells <xref ref-type="bibr" rid="pone.0078887-Paszek1">[15]</xref>. Although individual cell trajectories are very similar for IκB-deficient and wild-type cells, the latter are less synchronized, and therefore oscillations appear damped when averaged over population <xref ref-type="bibr" rid="pone.0078887-Paszek1">[15]</xref>,<xref ref-type="bibr" rid="pone.0078887-Lipniacki3">[35]</xref>. In the current study, we focus on TNFα autocrine regulation and neglect the regulatory differences between IκB and IκBα and replace these two proteins by a more abundant IκBα. The (NF-κB:IκBα) complexes may circulate between the nucleus and cytoplasm, however since they mostly accumulate in cytoplasm, which is visible in unstimulated cells (for which majority of NF-κB is bound to IκBα and other isoforms) <xref ref-type="bibr" rid="pone.0078887-Nelson1">[33]</xref>,<xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>,<xref ref-type="bibr" rid="pone.0078887-Ashall1">[73]</xref>, we neglect the nuclear import term for (NF-κB:IκBα). Accumulation of IκBα protein is enabled by A20 which attenuates the strength of the extracellular signal (discussed in Introduction). First, A20 attenuates the activity of TNFR1 receptors (which is the consequence of A20-induced degradation of RIP – the key component of the receptor complex). Second, it enhances conversion of catalytically active IKK (IKK), into catalytically inactive form (IKK). Inactive kinase IKK spontaneously converts back to the neutral form IKK through the intermediate form IKK. It is worth noticing here, that Ashall et al. <xref ref-type="bibr" rid="pone.0078887-Ashall1">[73]</xref> in their model variant assumed that A20 inhibits conversion of IKK to neutral form IKK, rather than it enhances conversion of IKK to IKK.</p>
</sec><sec id="s2b">
<title>Autocrine Tnfα Regulation</title>
<p>TNFα is one of NF-κB-responsive genes, and its expression level is cell type-dependent. 3T3 cells, which we studied experimentally in this work, exhibit a relatively low TNFα expression, reaching 20 mRNA molecules (on average) per cell at the highest TNFα stimulation dose, <xref ref-type="fig" rid="pone-0078887-g002">Fig. 2A</xref>. However, expression levels calculated per activated cell were independent of the TNFα dose showing digital responses similar to that of early genes we analyzed earlier <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>. The dynamic gene expression measurements show that the TNFα synthesis has a distinct peak at <italic>t</italic>  =  1 hour regardless of the TNFα dose, and shows a low plateau which extends to beyond 10 hours.</p>
<fig id="pone-0078887-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g002</object-id><label>Figure 2</label><caption>
<title>Evidence of TNFα synthesis and secretion in 3T3 cells and RAW cells.</title>
<p>(<bold>A</bold>) Time-course of population averaged expression of TNFα mRNA in mouse 3T3 fibroblast cells stimulated with various doses of TNFα; color lines from dark blue to yellow correspond to TNFα doses of 10, 1, 0.1 0.05, 0.025 and 0.01 ng/ml. Cells were treated with different doses of TNFα, and TNFα mRNA was quantified at different times using microfluidic qPCR. Microfluidic digital-PCR was used to calibrate expression levels to mRNA counts. (<bold>B</bold>, <bold>C</bold>) Representative ELISpot assays showing TNFα secretion by (<bold>B</bold>) unstimulated 3T3 and (<bold>C</bold>) RAW cells.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g002" position="float" xlink:type="simple"/></fig>
<p>Interestingly, we found that a small fraction (about 3%) of 3T3 cells secrete TNFα without any stimulation as shown by ELISpot assay, <xref ref-type="fig" rid="pone-0078887-g002">Fig. 2B</xref>. The fraction of secreting cells was found to be larger (about 10%) for RAW 264.7 (mouse leukaemic monocyte macrophage) cells, <xref ref-type="fig" rid="pone-0078887-g002">Fig. 2C</xref>. These measurements add to the evidence that TNFα production and secretion can be triggered spontaneously, and that probability of such spontaneous activations is cell line-dependent. Motivated by this observation, and earlier experimental studies demonstrating that TNFα induces TNFα synthesis via NF-κB activation (<xref ref-type="bibr" rid="pone.0078887-Coward1">[51]</xref>,<xref ref-type="bibr" rid="pone-0078887-Guergnon1">[52]</xref> as discussed in Introduction), we expanded our earlier model to include the TNFα autocrine regulation. Accordingly, we consider NF-κB-inducible TNFα mRNA synthesis, followed by TNFα protein translation and secretion. We assume that some fraction of secreted TNFα molecules may bind to receptors on the same cell, and that the fraction of captured TNFα molecules increases with the number of TNFR1 receptors according to the Hill function. The fraction of secreted TNFα which is not bound by receptors of the secreting cell is neglected in the considerations, but could be accounted for by modifying the extracellular TNFα concentration.</p>
<p>We analyze the evolution of the NF-κB system in the absence of any stimulation as well as its responses to the imposed concentrations of TNFα, considering both tonic and pulsed stimulation. In the whole analysis we account for intracellular and extracellular TNFα degradation, with degradation half-time  1 h (degradation rate of s), consistent with our earlier estimations <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>.</p>
</sec><sec id="s2c">
<title>Deterministic And Stochastic Modeling</title>
<p>We and others predicted and demonstrated that responses of the NF-κB system to low TNFα doses, as well as low LPS doses, are highly stochastic, and only a fraction of cells exhibit measurable NF-κB activation <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>,<xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>,<xref ref-type="bibr" rid="pone.0078887-James1">[74]</xref>,<xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>. Our ELISpot data on 3T3 cells and macrophages show that only a small fraction of cells secrete TNFα. Therefore, in order to analyze the autocrine TNFα regulation we will combine deterministic and stochastic modeling. In the deterministic approximation, the system of 25 ODEs is derived from the list of chemical reactions. The equations are then solved using M<sc>atlab</sc> and B<sc>io</sc>N<sc>et</sc>G<sc>en</sc> (<xref ref-type="supplementary-material" rid="pone.0078887.s002">Materials S1</xref> and <xref ref-type="supplementary-material" rid="pone.0078887.s003">S2</xref>). The deterministic approximation is used to analyze the dynamical structure of the regulatory system, which is needed to properly interpret more complex stochastic trajectories. Based on the bifurcation analysis performed using M<sc>at</sc>C<sc>ont</sc> continuation software (see <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref> and <xref ref-type="supplementary-material" rid="pone.0078887.s004">Material S3</xref>), we will show that unstimulated wild-type (WT) cells may have, depending on the strength of the autocrine regulation, two stable recurrent solutions: steady state and limit cycle, the latter corresponding to the cytoplasmic–nuclear NF-κB oscillations. In contrast, A20-deficient cells may simultaneously have two stable steady state solutions, corresponding to the active and inactive cells.</p>
<p>In the stochastic approach, chemical reactions are simulated using the direct Stochastic Simulation Algorithm <xref ref-type="bibr" rid="pone-0078887-gillespie1">[76]</xref> implemented in B<sc>io</sc>N<sc>et</sc>G<sc>en</sc>. B<sc>io</sc>N<sc>et</sc>G<sc>en</sc> is a rule-based specification language and environment <xref ref-type="bibr" rid="pone-0078887-g0aeder1">[77]</xref>. In B<sc>io</sc>N<sc>et</sc>G<sc>en</sc> language, models are constructed by specifying rules that describe allowed protein–protein interactions, processes, and covalent modifications. Based on the rules, the reaction network is automatically generated along with the system of ODEs. The advantage of this approach is that it allows for concise definitions of models with large numbers of interactions and protein states <xref ref-type="bibr" rid="pone.0078887-Barua1">[78]</xref>. Here, the model is relatively small, and the B<sc>io</sc>N<sc>et</sc>G<sc>en</sc> software is used because of its very efficient implementation of the Stochastic Simulation Algorithm (direct method). Trajectories obtained in stochastic simulations are interpreted as single cell trajectories. These trajectories, as we will see, may switch between the attractors of the deterministic approximation or may exhibit the excitatory behavior. Stochastic simulations will be used to determine the fraction of responding cells as a function of the TNFα dose. Averages over a large number of stochastic trajectories will be used to fit the model to the population data. As demonstrated before, in non-linear systems, the average over a large number of stochastic trajectories may qualitatively differ from the trajectory obtained in the deterministic approximation, and thus the deterministic approximation of the process may not satisfactorily reproduce population data <xref ref-type="bibr" rid="pone.0078887-Lipniacki5">[79]</xref>. In the stochastic model two types of noise are considered:</p>
<sec id="s2c1">
<title>Extrinsic Noise</title>
<p>The analysis performed in our previous study <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref> indicated for a broad distribution of TNFR1 receptor number across the cell population. The heterogeneity of NF-κB expression is of smaller importance, and will be neglected here for the sake of simplicity. Following <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref> we assume that the number of receptors is log-normally distributed with probability density  (see also Fig. S1 in <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref>),with  and . Such distribution is characterized by median , mean  and variance . In the deterministic approximation, if not otherwise specified, we assumed that the number of receptors  is equal to median .</p>
</sec><sec id="s2c2">
<title>Intrinsic Noise</title>
<p>Intrinsic noise in the system results mainly from the discrete regulation of TNFR1 receptors activity and activation of A20, IκBα, and TNFα genes, see <xref ref-type="bibr" rid="pone.0078887-Lipniacki4">[36]</xref>,<xref ref-type="bibr" rid="pone.0078887-Raj1">[80]</xref>. We found, however, that at low or zero dose stimulation, when the number of A20, IκBα, and TNFα mRNA molecules is very low, the transcriptional noise is also important. Accordingly, in contrast to our earlier studies <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>,<xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>,<xref ref-type="bibr" rid="pone.0078887-Lipniacki3">[35]</xref> that relied on Haseltine and Rawlings algorithm <xref ref-type="bibr" rid="pone.0078887-Haseltine1">[81]</xref>, in the current study we perform all stochastic simulations using the direct method of Gillespie <xref ref-type="bibr" rid="pone-0078887-gillespie1">[76]</xref>.</p>
</sec></sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Analysis Of The Deterministic Model</title>
<sec id="s3a1">
<title>Wild-Type Cells</title>
<p>The presence of the negative feedback loop together with the delay introduced by the mRNA transcription, protein translation and cytoplasmic to nuclear transport induces oscillatory responses to tonic TNFα stimulation. One can thus expect that cells which produce and secrete TNFα can exhibit tonic oscillations even without any external stimulation, being constantly activated by TNFα they secrete. In the bifurcation analysis (<xref ref-type="fig" rid="pone-0078887-g003">Fig. 3</xref>; see also <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref>, Fig. S3 for a 3-D plot), we consider the system without any external stimulation, i.e. assuming that the extracellular TNFα concentration equals zero. As a bifurcation parameter we choose TNFα mRNA synthesis rate , i.e., mRNA synthesis from a single active TNFα gene copy. The analysis shows that until the TNFα synthesis rate remains low, , the system may not exhibit persistent (limit cycle) oscillations. The only recurrent solution is the stable steady state in which the nuclear NF-κB fraction is low (below 0.01). At  mRNA/s, the stable limit cycle arises in the cyclic fold bifurcation, and for intermediate TNFα synthesis rates, , the oscillatory solution coexist with the stable steady state solution. The further growth of the TNFα synthesis rate causes that the stable steady state solution loses its stability in bifurcation at  mRNA/s, and in a broad range of  the stable limit cycle is the only stable recurrent solution. A scrupulous analysis of the bifurcation at  showed that in the very close vicinity of  there are in fact two bifurcations: supercritical Hopf at  and cyclic fold at  (see <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref>, Fig. S2). These two bifurcations in coarse-grained view are equivalent to the single subcritical Hopf bifurcation and in further discussion will be considered as such. Finally, at  mRNA/s the limit cycle oscillations are replaced by a single stable steady state. We should notice, however, that  mRNA/s exceeds the physiological maximum transcriptional rate estimated as  mRNA/s, assumed in the model for A20 and IκBα, known for very rapid mRNA synthesis (see <xref ref-type="bibr" rid="pone.0078887-Lipniacki3">[35]</xref>). In summary, we found that within the deterministic approximation, in the absence of stimulation, WT cells remain in the inactive state when TNFα synthesis rate is low (), or exhibit limit cycle oscillations for the high TNFα synthesis rate (). For intermediate TNFα synthesis rates  cells may either remain in the inactive state or exhibit limit cycle oscillations. The values of bifurcation points, in particular  at which limit cycle oscillations arise, decrease (almost linearly for small TNFR1 numbers) with cell sensitivity which is proportional to the assumed level of TNFR1 receptors, <xref ref-type="fig" rid="pone-0078887-g003">Fig. 3F</xref>.</p>
<fig id="pone-0078887-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g003</object-id><label>Figure 3</label><caption>
<title>Bifurcation diagrams for WT cells.</title>
<p>Recurrent solutions in a function of TNFα mRNA transcription coefficient . (<bold>A</bold>–<bold>D</bold>) Nuclear NF-κB, free cytoplasmic IκBα, A20, intracellular TNFα. There are three bifurcations: cyclic fold (CF) at , subcritical Hopf at (see <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref> and Fig. S3 therein for details) and supercritical Hopf at . (<bold>E</bold>) Oscillation period of stochastic and deterministic trajectories as a function of . (<bold>F</bold>) Cyclic fold bifurcation parameter  as a function of TNFR1 receptor number. Bifurcations diagrams shown in (<bold>A</bold>–<bold>D</bold>) where obtained for receptor number  (equal to the median receptor number assumed for stochastic simulations).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3a2">
<title>A20-Deficient Cells</title>
<p>In A20 cells the negative feedback is disturbed. Since A20 promotes transformation from active IKK (IKK) to inactive IKK (IKK), lack of A20 results in the prolonged IKK activity. This in turn prevents the accumulation of IκBα protein and results in the persistent nuclear NF-κB occupancy. As a result, in response to the tonic TNFα stimulation, A20-deficient cells do not exhibit limit cycle oscillation, but reach the active steady state, characterized by a high IKK activity, a high level of nuclear NF-κB and correspondingly high level of IκBα transcript, but low level of IκBα protein, which is constantly degraded due to the high IKK activity. One can thus expect that A20 cells which synthesize and secrete TNFα may remain in the active state, without external stimulation. In fact, the bifurcation analysis (<xref ref-type="fig" rid="pone-0078887-g004">Fig. 4</xref>) demonstrated that there exists a broad range of TNFα mRNA synthesis rate , , in which the system is bistable, i.e., it can remain either in the active state (with high nuclear NF-κB level) or the inactive state (with low nuclear NF-κB level). The value of parameter  mRNA/s in which the active steady state appears (in saddle-node bifurcation) is very low, more than 10 times lower than the value of bifurcation parameter in which limit cycle oscillations arise in WT cells. The value of the second saddle-node bifurcation, , in which the inactive steady state vanishes, is much larger,  mRNA/s. As a result, one may expect that A20-deficient cells will remain inactive without any stimulation, but even transient TNFα stimulation will drive them to the active state, in which they can remain for a long time (formally, infinitely long time).</p>
<fig id="pone-0078887-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g004</object-id><label>Figure 4</label><caption>
<title>Bifurcation diagrams for A20-deficient cells.</title>
<p>Stable recurrent solutions in a function of TNFα mRNA transcription coefficient . (<bold>A</bold>–<bold>D</bold>) Nuclear NF-κB, free cytoplasmic IBα, active IKK, intracellular TNFα. There are two saddle-node bifurcations at and.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g004" position="float" xlink:type="simple"/></fig>
<p>The bifurcation analysis of the deterministic model demonstrated that due to the positive feedback regulation, even in the absence of any external stimulation, WT cells exhibit limit cycle oscillations while A20-deficient cells exhibit persistent activation, provided that TNFα mRNA synthesis rate is sufficiently large. The A20 cells were found to be much more sensitive, i.e., they can remain active for 10 times lower TNFα synthesis rate than needed for WT cells activation. In addition, we found that both A20 and WT cells exhibit bistability: in WT cells it is manifested by the coexistence of the stable limit cycle and the stable steady state. One can thus expect that real (noisy) cells will exhibit transitions between the basins of attraction of recurrent solutions found in the deterministic analysis.</p>
</sec></sec><sec id="s3b">
<title>Stochastic Switching In The Absence Of Tnfα Stimulation</title>
<p>In <xref ref-type="fig" rid="pone-0078887-g005">Fig. 5</xref> we compare deterministic and stochastic trajectories projected onto the (‘Nuclear NF-κB’, ‘Total IκBα’) plane. For  mRNA/s (<xref ref-type="fig" rid="pone-0078887-g005">Fig. 5A</xref>) the system in the deterministic approximation has the stable steady state and the stable limit cycle. As expected, the stochastic trajectory switches between limit cycle oscillations and small fluctuations in the vicinity of the inactive steady state. The large magnitude of noise causes large departures from the stable orbit of the deterministic approximation. For the twice smaller value of  mRNA/s (<xref ref-type="fig" rid="pone-0078887-g005">Fig. 5B</xref>), the inactive steady state is the only recurrent solution of the deterministic system. The deterministic trajectory (red line), after the large departure from this unique stable steady state in response to the 5-min 1 ng/ml TNFα pulse, exhibits a series of four oscillations before returning to the close vicinity of the steady state. In contrast, a stochastic trajectory may exhibit longer series of semi-periodic oscillations, without any TNFα stimulation (black line). The phenomenon of noise-induced oscillations is quite common in dynamical systems; here, the oscillations are additionally stabilized by the “ghost” of the limit cycle.</p>
<fig id="pone-0078887-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g005</object-id><label>Figure 5</label><caption>
<title>Stochastic versus deterministic solutions for WT cells.</title>
<p>(<bold>A</bold>) ; thick red line and red dot – stable limit cycle and stable steady state for the deterministic approximation; blue line – example stochastic trajectory (total simulation time: 70 h). (<bold>B</bold>) ; red line – deterministic damped oscillations in response to 5-min pulsed 1 ng/ml TNFα; blue line – example stochastic trajectory (total simulation time: 70 h) in the absence of TNFα stimulation.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g005" position="float" xlink:type="simple"/></fig>
<p>In <xref ref-type="fig" rid="pone-0078887-g006">Fig. 6</xref> we analyze stochastic switching of WT and A20 cells. WT cells are analyzed for two TNFα transcription coefficients  mRNA/s (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6A</xref>) and  mRNA/s (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6B</xref>). In the first case, 3000-hour-long simulation reveals irregular jumps between the inactive and the oscillatory phases (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6A</xref>). In the inactive phase (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6C</xref>), the nuclear NF-κB fluctuations are irregular and their amplitude is of order of  molecules. In contrast, in the oscillatory phase, the oscillations are semiperiodic with the average amplitude of  molecules (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6D</xref>), more than an order of magnitude larger than in the inactive phase. For  the stochastic transitions between the inactive and the oscillatory phases occur on average every 70 h, and the fraction of time spent in each phase is almost equal. For smaller  mRNA/s, for which the deterministic system is monostable, transitions to the oscillatory phase are still possible, but the characteristic number of oscillations in a series is smaller. As one could expect, the probability that a cell is in the oscillatory phase grows with  (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6E</xref>). A bit surprisingly, even when the deterministic approximation is monostable ( mRNA/s), the oscillatory phase probability is nonzero, and, similarly, when the deterministic systems has only limit cycle oscillations ( mRNA/s), the oscillatory phase probability may still be smaller than 1.</p>
<fig id="pone-0078887-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g006</object-id><label>Figure 6</label><caption>
<title>Long run stochastic trajectories in the absence of external stimulation.</title>
<p>(<bold>A</bold>, <bold>B</bold>) WT cells for  = 0.05 and  = 0.025, respectively, and TNFR1 receptors number  = 7000. (<bold>C</bold>, <bold>D</bold>) Zoomed fragments of trajectory showing (<bold>C</bold>) small stochastic fluctuations in the vicinity of the stable steady state and (<bold>D</bold>) large amplitude oscillations in the basin of attraction of the stable limit cycle. (<bold>E</bold>) Fraction of oscillating WT and A20 cells as a function of . (<bold>F</bold>, <bold>G</bold>) A20 cells trajectories for  = 0.006 and  = 0.004.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g006" position="float" xlink:type="simple"/></fig>
<p>As already said, A20-deficient cells are more sensitive to TNFα, and they are activated at a much smaller TNFα transcription coefficient . This property is even more evident when the stochastic system is analyzed. For  the transitions to the active state are very infrequent (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6G</xref>), but for larger  cells spend more than half of time in the active state. Despite the deterministic system is bistable for , it appears that the stochastic system is persistently active for  (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6E</xref> and <xref ref-type="supplementary-material" rid="pone.0078887.s001">Text S1</xref>, Fig. S4C).</p>
</sec><sec id="s3c">
<title>Individual Cell Responses To Different Tnfα Doses</title>
<sec id="s3c1">
<title>Wild-Type Cells</title>
<p>Turner et al. <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref> found that about 20% of unstimulated SK-N-AS cells exhibit NF-κB oscillations without any stimulation. In light of our model, this finding suggests that these cell express TNFα, and that the TNFα transcription coefficient, , is about  mRNA/s (or, more precisely, that effectiveness of TNFα transcription, translation and secretion process is such as in the model for  mRNA/s). As shown in <xref ref-type="fig" rid="pone-0078887-g006">Fig. 6E</xref> for this , the probability to find a cell in the oscillatory phase is about 20%. More precisely, the fitted value of , as well as the cyclic fold bifurcation parameter , depend on the assumed level of TNFR1 receptors (<xref ref-type="fig" rid="pone-0078887-g003">Fig. 3F</xref>). Keeping the experiment of Turner et al. as a reference for SK-N-AS cells, we set  mRNA/s <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>. As shown in <xref ref-type="fig" rid="pone-0078887-g003">Fig. 3E</xref> for  the oscillation period (of spontaneous oscillation) is about 110 min in agreement with experimental data, and then decreases with the value of . Accordingly, for  we simulate cell responses to four TNFα doses. In simulations the level of TNFα is increased abruptly in  h from 0 to respectively 1 ng/ml, 100 pg/ml, 30 pg/ml, 3 pg/ml, and then decreases exponentially with half-time of ∼1 h due to protein degradation (<xref ref-type="fig" rid="pone-0078887-g007">Fig. 7</xref>).</p>
<fig id="pone-0078887-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g007</object-id><label>Figure 7</label><caption>
<title>Simulated responses of WT cells (with  = 0.025) to tonic TNFα stimulation beginning at  = 1 h.</title>
<p>(<bold>A</bold>–<bold>D</bold>): TNFα doses: 1 ng/ml, 100 pg/ml, 30 pg/ml, 3 pg/ml. Red thick line – deterministic simulation; thin colored lines – single cell stochastic simulations; black thick line – population average. In (<bold>A</bold>) and (<bold>B</bold>), 3 individual representative cells trajectories are shown (in each panel). In (<bold>C</bold>) and (<bold>D</bold>), respectively 5 and 10 individual cell trajectories are shown, but only 3 trajectories (in each panel) exhibit visible oscillations.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g007" position="float" xlink:type="simple"/></fig>
<p>The single cell trajectories obtained in numerical simulations (<xref ref-type="fig" rid="pone-0078887-g007">Fig. 7</xref>) are in plausible agreement with the experiment of Turner et al. <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>. In particular, both experiment and simulation showed that the amplitude of the first pulse decreases with dose, but the amplitudes of subsequent peaks are higher for the low than for the high dose.</p>
<p>The low dose (≤30 pg/ml) responses have a purely stochastic nature. They are not observed in the deterministic simulations (thick red line), and are invisible at the population level due to the asynchrony of individual cells. The average activation time and its variance increases with decreasing TNFα dose, which suggests that the first activation has a stochastic character. As predicted and demonstrated recently, massive NF-κB translocation may follow binding of single TNFα molecules to TNFR1 receptors <xref ref-type="bibr" rid="pone.0078887-Lipniacki2">[27]</xref>,<xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>. However, even at low doses the first peak is frequently followed by subsequent ones, which according to the model is due to (1) autoactivation via autocrine TNFα regulation and (2) broad distribution of the level of receptors. Responding cells likely have higher receptor number so they are more prone for subsequent activation <xref ref-type="bibr" rid="pone.0078887-Tay1">[34]</xref>.</p>
<p>As found by Turner et al., the fraction of activated cells in first 300 minutes decreases with TNFα dose, but even for zero doses the activated cell fraction is about 20% <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>. This phenomenon is clearly visible in our simulation (<xref ref-type="fig" rid="pone-0078887-g008">Fig. 8</xref>). Following Turner et al., we analyze two cases: tonic TNFα stimulation, and 5-min TNFα pulse <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>. As expected, for the same dose, tonic stimulation yield higher fraction of responding cells. The model predictions are in reasonable agreement with experiment, with the main difference being observed for the tonic stimulation. For 3 pg/ml the model predicts lower fraction of responding cells than that observed experimentally. This can be attributed to the paracrine activation of neighboring cells, which is not taken into account in the model. Paracrine signaling can be also responsible for huge error bars for 3 pg/ml dose: one can imagine that the denser arrays of cells are more prone to activation.</p>
<fig id="pone-0078887-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g008</object-id><label>Figure 8</label><caption>
<title>Fraction of responding cells versus TNF<italic>α</italic>dose.</title>
<p>(<bold>A</bold>) Tonic stimulation. (<bold>B</bold>) 5-min pulsed stimulation. Color bars: model prediction for  = 0.025– fraction of cells responding within the given time period. Error bars show fractions of cells responding during the first 300-min in the experiment of Turner et al. <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref> on SK-N-AS cells, see the main text.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g008" position="float" xlink:type="simple"/></fig></sec><sec id="s3c2">
<title>A20-Deficient Cells</title>
<p>In their seminal work, Lee et al. observed that A20 MEFs (in contrast to WT cells) do not exhibit oscillations to the tonic TNFα stimulation <xref ref-type="bibr" rid="pone.0078887-Lee2">[14]</xref>. More surprisingly, Werner et al. (2005 and 2008) observed that in A20 MEFs even a short 5-min pulse of TNFα stimulation leads to at least 3-hour-long nuclear NF-κB activity <xref ref-type="bibr" rid="pone.0078887-Werner1">[82]</xref>,<xref ref-type="bibr" rid="pone.0078887-Werner2">[83]</xref>. As already found in the deterministic model analysis, A20 cells producing even small amounts of TNFα are bistable, and thus may be “persistently” activated by a short pulse of TNFα.</p>
<p>In <xref ref-type="fig" rid="pone-0078887-g009">Fig. 9</xref> we compare WT and A20 cell responses to 5-, 15- and 45-min TNFα stimulation. We assume TNFα mRNA synthesis rate , much smaller than the value for SK-N-AS cells. This is in accordance with the observation that 3T3 cells do not exhibit spontaneous activation. WT cells respond with a single pulse of IKK activity, which leads in most cases to a single pulse of nuclear NF-κB. In contrast, A20 cells show a high tail of IKK activity, which results in the prolonged nuclear NF-κB occupancy. In the deterministic model (thick red line), 5- and 15-min pulses are not sufficient to drive cells into the active state; only after the 45-min pulse cells became persistently activated. In contrast, most of single cell stochastic trajectories exhibit a high level of nuclear NF-κB even after the 5-min pulse. As a result, the population average trajectory shows single NF-κB pulse followed by a very high tail. The IKK and NF-κB activity profiles for WT and A20 are in plausible agreement with experiments of Werner et al. <xref ref-type="bibr" rid="pone.0078887-Werner1">[82]</xref>,<xref ref-type="bibr" rid="pone.0078887-Werner2">[83]</xref>.</p>
<fig id="pone-0078887-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0078887.g009</object-id><label>Figure 9</label><caption>
<title>Simulated responses of WT and A20 cells to pulsed stimulation with 1 ng/ml TNFα for  = 0.004.</title>
<p>(<bold>A</bold>) 5-min pulse. (<bold>B</bold>) 15-min pulse. (<bold>C</bold>) 45-min pulse. Red thick line – deterministic simulation; thin colored lines – single cell stochastic simulations; black thick line – population average.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0078887.g009" position="float" xlink:type="simple"/></fig></sec></sec></sec><sec id="s4">
<title>Discussion</title>
<p>We investigated theoretically and computationally the effect of autocrine TNFα signaling on NF-κB regulation. NF-κB activity is regulated by two interlinked negative feedback loops. The first loop involves NF-κB responsive inhibitors: IκBα and IκB, which directly bind to NF-κB and sequester it in the cytoplasm. The second loop is mediated by another NF-κB strongly responsive protein, A20, which attenuates the IKK activity. Without A20 expression, IKK retains its activity, which leads to the rapid degradation of the newly synthesized IκBα and destroys the NF-κB–IκBα feedback loop. The autocrine positive feedback loop arises in cell lines that are characterized by a sufficiently high TNFR1 expression and TNFα secretion. As demonstrated in this study, the positive feedback qualitatively changes the system dynamics. It may lead to long-lasting NF-κB oscillations in WT cells and persistent NF-κB activity in A20-deficient cells, which were found to be very prone to activation. The approach proposed in this study combined deterministic and stochastic modeling.</p>
<p>Bifurcation analysis was performed for WT and A20-deficient cells. In both cases, TNFα mRNA synthesis rate was chosen as a bifurcation parameter . Analysis of WT cells shown in <xref ref-type="fig" rid="pone-0078887-g003">Fig. 3</xref> revealed that at some value of  the limit cycle oscillations appear. These oscillations coexist with steady state (characterized by low level of nuclear NF-κB), which loses stability for . That is, in range of bifurcation parameter   the system has two stable recurrent solutions, steady state and limit cycle. In contrast to WT cells, A20-deficient cells (considered in the deterministic approximation) do not exhibit oscillations. Instead, in a broad range of bifurcation parameter they exhibit bistability characterized by the coexistence of states of the low and high level of nuclear NF-κB. The A20 deficiency dramatically increases cell sensitivity: the critical value of TNFα synthesis at which cells may be activated due to autocrine signaling was found more than 10 times lower for A20 cells than for WT cells, ∼0.0037 mRNA/s (for A20) versus ∼0.045 mRNA/s (for WT).</p>
<p>By analyzing the stochastic model we demonstrated that noise, arising mostly at the level of gene regulation, enables switching between the stable steady state and limit cycle in WT cells, and between inactive and active steady state in A20-deficient cells (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6</xref>). Interestingly, in WT cells the semiperiodic oscillations can be driven by noise even for , i.e., in the absence of the limit cycle (<xref ref-type="fig" rid="pone-0078887-g006">Fig. 6E</xref>). This can be interpreted as <italic>stochastic resonance</italic>, which in the broad definition refers to the case when noise has a positive role in the signal-processing context <xref ref-type="bibr" rid="pone.0078887-McDonnell1">[84]</xref>. The transition from the inactive to the oscillatory state can be also induced by an external TNFα stimulation, and the probability of such transition increases with the stimulation dose (<xref ref-type="fig" rid="pone-0078887-g007">Figs. 7</xref> and <xref ref-type="fig" rid="pone-0078887-g008">8</xref>). Based on our analysis, one should also expect that the LPS stimulation leading to the activation of NF-κB (which controls TNFα transcription) and MAPK pathways (effector kinases which stabilize TNFα transcript and enhance TNFα translation), which together results in massive secretion of TNFα, can also trigger long-lasting NF-κB oscillations in cells with high autocrine potential <xref ref-type="bibr" rid="pone.0078887-Lee1">[4]</xref>,<xref ref-type="bibr" rid="pone-0078887-Gutschow1">[68]</xref>.</p>
<p>Introduction of positive feedback enabled us to reproduce the noise-triggered oscillations observed by Turner et al. in unstimulated cells, as well as earlier experiments by Werner et al. showing prolonged NF-κB activation in response to the pulsed TNFα stimulation in A20-deficient MEFs <xref ref-type="bibr" rid="pone.0078887-Turner1">[75]</xref>,<xref ref-type="bibr" rid="pone.0078887-Werner1">[82]</xref>,<xref ref-type="bibr" rid="pone.0078887-Werner2">[83]</xref>. Since the sensitivity to the autocrine-driven activation of A20-deficient cells is much higher than that of WT cells, even a weak stimulus can drive these cells to the state of persistent NF-κB activation characterized by massive secretion of TNFα and other inflammatory cytokines such as IL-8 and IL-6. This explains why the loss of A20 or its dysfunction disturbs regulation of immune system and renders the organism vulnerable to the septic shock resulting from the uncontrolled secretion of inflammatory cytokines <xref ref-type="bibr" rid="pone.0078887-Vodovotz1">[85]</xref>. Mice lacking A20 are hypersensitive to the TNFα-induced cell death, which suggests that positive auto- and paracrine signaling upregulate the TNFα expression so strongly that it overcomes the antiapoptotic action of NF-κB <xref ref-type="bibr" rid="pone.0078887-Lee2">[14]</xref>. Boone et al. demonstrated that A20 is critical for the regulation of macrophage responses in vivo and protects mice against the septic shock <xref ref-type="bibr" rid="pone.0078887-Boone1">[28]</xref>.</p>
<p>There is a bulk of evidence that the loss or dysfunction of A20 as well as the other inhibitory DUBase, named Cyld, promote inflammatory diseases and cancer (reviewed in <xref ref-type="bibr" rid="pone.0078887-Harhaj1">[24]</xref>,<xref ref-type="bibr" rid="pone.0078887-Hymowitz1">[86]</xref>). It was found recently that A20 functions as a tumor suppressor in several subtypes of non-Hodgkin as well as Hodgkin lymphomas, and its silencing results in the constitutive activation of NF-κB <xref ref-type="bibr" rid="pone.0078887-Honma1">[29]</xref>,<xref ref-type="bibr" rid="pone.0078887-Kato1">[87]</xref>. Kato et al. found that when re-expressed in a lymphoma-derived cell line with no functional A20 alleles, wild-type A20, but not mutant A20, resulted in the suppression of cell growth and induction of apoptosis, accompanied by downregulation of NF-κB activation <xref ref-type="bibr" rid="pone.0078887-Kato1">[87]</xref>. Somatic mutations of A20 are associated with constitutive activation of NF-κB and poor overall survival in diffuse large B-cell lymphoma <xref ref-type="bibr" rid="pone.0078887-Dong1">[88]</xref>. Huang et al. observed that the loss of A20 expression accompanies the oncogenic transformation of MEFs <xref ref-type="bibr" rid="pone.0078887-Huang1">[89]</xref>. The above findings indicate that constitutive NF-κB activation, resulting form A20 dysfunction or increased TNFα autocrine potential (due to elevated TNFα and/or TNFR1 expression), in general promote cancer <xref ref-type="bibr" rid="pone.0078887-JacksonBernitsas1">[90]</xref>,<xref ref-type="bibr" rid="pone.0078887-Lisby1">[91]</xref>. In correspondence to our considerations, Bian et al. found that constitutively active NF-κB is required for the survival of S-type neuroblastic SH-EP1 and SK-N-AS cell lines <xref ref-type="bibr" rid="pone.0078887-Bian1">[92]</xref>.</p>
<p>As already said, particular cell lines are characterized by the high TNFα autocrine potential. Macrophages are generally considered as major TNFα producers, and are also highly TNFα-responsive. There is a growing evidence that macrophages require autocrine TNFα regulation for survival and differentiation <xref ref-type="bibr" rid="pone.0078887-Lombardo1">[93]</xref>–<xref ref-type="bibr" rid="pone.0078887-Parameswaran1">[95]</xref>. In monocytes, sustained Nrf2 activation that protects cells from oxidative damage involves TNFα autocrine signaling <xref ref-type="bibr" rid="pone.0078887-Rushworth1">[56]</xref>.</p>
<p>In summary, the proposed model explains the mechanism of spontaneous or signal-dependent activation of NF-κB in cells with high autocrine potential. The cells prone to autocrine activation are characterized by high level of TNFα and TNFR1 synthesis or loss of functional A20. A20 dysfunction may promote inflammation and cancer, and also render the organism vulnerable to septic shock. In some cell lines, however, the self-sustained NF-κB activation can be required for performing their functions or undergo differentiation.</p>
</sec><sec id="s6">
<title>Supporting Information</title>
<supplementary-material id="pone.0078887.s001" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pone.0078887.s001" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>The supplementary text includes: list of reactions and parameters, list of differential equations, numerical simulation protocols, mathematical methods and experimental protocols, and four supplementary figures: Fig. S1– distribution of the number of receptors; Fig. S2– close-up on the bifurcation diagram near  for WT cells; Fig. S3––3-D bifurcation diagram for WT cells; Fig. S4– long run stochastic trajectories for WT cells for <italic>λ</italic> = 0.1 and <italic>λ</italic> = 0.2 and for A20 cells for <italic>λ</italic> = 0.01.</bold></p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pone.0078887.s002" mimetype="application/zip" xlink:href="info:doi/10.1371/journal.pone.0078887.s002" position="float" xlink:type="simple"><label>Material S1</label><caption>
<p><bold>M<sc>atlab</sc> code of the model for performing deterministic simulations. (ZIP-archived directory containing M<sc>atlab</sc> scripts and a ReadMe file).</bold></p>
<p>(ZIP)</p>
</caption></supplementary-material><supplementary-material id="pone.0078887.s003" mimetype="application/zip" xlink:href="info:doi/10.1371/journal.pone.0078887.s003" position="float" xlink:type="simple"><label>Material S2</label><caption>
<p><bold>B<sc>io</sc>N<sc>et</sc>G<sc>en</sc> code of the model for performing both deterministic and stochastic simulations. (ZIP-archived directory containing a BNGL model file and a ReadMe file).</bold></p>
<p>(ZIP)</p>
</caption></supplementary-material><supplementary-material id="pone.0078887.s004" mimetype="application/zip" xlink:href="info:doi/10.1371/journal.pone.0078887.s004" position="float" xlink:type="simple"><label>Material S3</label><caption>
<p><bold>M<sc>atlab</sc>/M<sc>atcont</sc> code for performing bifurcation analysis. (ZIP-archived directory containing M<sc>atlab</sc> scripts calling M<sc>atcont</sc> functions, and a ReadMe file).</bold></p>
<p>(ZIP)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0078887-Yde1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yde</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mengel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Krishna</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Trusina</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>Modeling the NF-κB mediated inflammatory response predicts cytokine waves in tissue</article-title>. <source>BMC Syst Biol</source> <volume>5</volume>: <fpage>115</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Rand1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rand</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Rinas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schwerk</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nöhren</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Linnes</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response</article-title>. <source>Mol Syst Biol</source> <volume>8</volume>: <fpage>584</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Covert1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Covert</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Gaston</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>2005</year>) <article-title>Achieving stability of lipopolysaccharideinduced NF-<italic>κ</italic>B activation</article-title>. <source>Science</source> <volume>309</volume>: <fpage>1854</fpage>–<lpage>1857</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lee1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Denny</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Sanghvi</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Gaston</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Maynard</surname><given-names>ND</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>A noisy paracrine signal determines the cellular NF-<italic>κ</italic>B response to lipopolysaccharide</article-title>. <source>Sci Signal</source> <volume>2</volume>: <fpage>ra65</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Brasier1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brasier</surname><given-names>AR</given-names></name> (<year>2006</year>) <article-title>The NF-<italic>κ</italic>B regulatory network</article-title>. <source>Cardiovasc Toxicol</source> <volume>6</volume>: <fpage>111</fpage>–<lpage>130</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hoffmann1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>Circuitry of nuclear factor <italic>κ</italic>B signaling</article-title>. <source>Immunol Rev</source> <volume>210</volume>: <fpage>171</fpage>–<lpage>186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Brown1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kanno</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Franzoso</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Siebenlist</surname><given-names>U</given-names></name> (<year>1993</year>) <article-title>Mutual regulation of the transcriptional activator NF-<italic>κ</italic>B and its inhibitor, I<italic>κ</italic>B-<italic>α</italic></article-title>. <source>Proc Natl Acad Sci USA</source> <volume>90</volume>: <fpage>2532</fpage>–<lpage>2536</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hoffmann2"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Levchenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>2002</year>) <article-title>The I<italic>κ</italic>B–NF-<italic>κ</italic>B signaling module: temporal control and selective gene activation</article-title>. <source>Science</source> <volume>298</volume>: <fpage>1241</fpage>–<lpage>1245</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Cho1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cho</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Wolkenhauer</surname><given-names>O</given-names></name> (<year>2003</year>) <article-title>Investigations into the analysis and modeling of the TNF<italic>α</italic>-mediated NF-<italic>κ</italic>B-signaling pathway</article-title>. <source>Genome Res</source> <volume>13</volume>: <fpage>2413</fpage>–<lpage>2422</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Whiteside1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whiteside</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Epinat</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Isral</surname><given-names>A</given-names></name> (<year>1997</year>) <article-title>I<italic>κ</italic>B, a novel member of the I<italic>κ</italic>B family, controls RelA and cRel NF-<italic>κ</italic>B activity</article-title>. <source>EMBO J</source> <volume>16</volume>: <fpage>1413</fpage>–<lpage>1426</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kearns1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kearns</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Basak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Werner</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>I<italic>κ</italic>B provides negative feedback to control NF-<italic>κ</italic>B oscillations, signaling dynamics, and inflammatory gene expression</article-title>. <source>J Cell Biol</source> <volume>173</volume>: <fpage>659</fpage>–<lpage>664</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Krikos1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krikos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Laherty</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name> (<year>1992</year>) <article-title>Transcriptional activation of the tumor necrosis factor <italic>α</italic>-inducible zinc finger protein, a20, is mediated by <italic>κ</italic>B elements</article-title>. <source>J Biol Chem</source> <volume>267</volume>: <fpage>17971</fpage>–<lpage>17976</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Jttel1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jttel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mouritzen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Elling</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bastholm</surname><given-names>L</given-names></name> (<year>1996</year>) <article-title>A20 zinc finger protein inhibits TNF and IL-1 signaling</article-title>. <source>J Immunol</source> <volume>156</volume>: <fpage>1166</fpage>–<lpage>1173</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lee2"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Boone</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Chai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Libby</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Chien</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Failure to regulate TNF-induced NF-<italic>κ</italic>B and cell death responses in A20-deficient mice</article-title>. <source>Science</source> <volume>289</volume>: <fpage>2350</fpage>–<lpage>2354</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Paszek1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ashall</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sillitoe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>CV</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Population robustness arising from cellular heterogeneity</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>107</volume>: <fpage>11644</fpage>–<lpage>11649</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Zhang1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>SQ</given-names></name>, <name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cantarella</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wallach</surname><given-names>D</given-names></name> (<year>2000</year>) <article-title>Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation</article-title>. <source>Immunity</source> <volume>12</volume>: <fpage>301</fpage>–<lpage>311</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Mauro1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mauro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pacifico</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lavorgna</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mellone</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iannetti</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-<italic>κ</italic>B</article-title>. <source>J Biol Chem</source> <volume>281</volume>: <fpage>18482</fpage>–<lpage>18488</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Skaug1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skaug</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>F</given-names></name>, <name name-style="western"><surname>He</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Direct, noncatalytic mechanism of IKK inhibition by A20</article-title>. <source>Mol Cell</source> <volume>44</volume>: <fpage>559</fpage>–<lpage>571</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Wertz1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wertz</surname><given-names>IE</given-names></name>, <name name-style="western"><surname>O’Rourke</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eby</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aravind</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-<italic>κ</italic>B signalling</article-title>. <source>Nature</source> <volume>430</volume>: <fpage>694</fpage>–<lpage>699</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Delhase1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Delhase</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hayakawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Karin</surname><given-names>M</given-names></name> (<year>1999</year>) <article-title>Positive and negative regulation of I<italic>κ</italic>B kinase activity through IKK<italic>β</italic> subunit phosphorylation</article-title>. <source>Science</source> <volume>284</volume>: <fpage>309</fpage>–<lpage>313</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Chen1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name> (<year>2012</year>) <article-title>Ubiquitination in signaling to and activation of IKK</article-title>. <source>Immunol Rev</source> <volume>246</volume>: <fpage>95</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Zhou1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wertz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>O’Rourke</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ultsch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Seshagiri</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Bcl10 activates the NF-<italic>κ</italic>B pathway through ubiquitination of NEMO</article-title>. <source>Nature</source> <volume>427</volume>: <fpage>167</fpage>–<lpage>171</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hutti1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hutti</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Asara</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>I<italic>κ</italic>B kinase <italic>β</italic> phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-<italic>κ</italic>B pathway</article-title>. <source>Mol Cell Biol</source> <volume>27</volume>: <fpage>7451</fpage>–<lpage>7461</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Harhaj1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harhaj</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name> (<year>2011</year>) <article-title>Deubiquitinases in the regulation of NF-<italic>κ</italic>B signaling</article-title>. <source>Cell Res</source> <volume>21</volume>: <fpage>22</fpage>–<lpage>39</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Harhaj2"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harhaj</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name> (<year>2012</year>) <article-title>Regulation of NF-<italic>κ</italic>B by deubiquitinases</article-title>. <source>Immunol Rev</source> <volume>246</volume>: <fpage>107</fpage>–<lpage>124</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lipniacki1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brasier</surname><given-names>ARAR</given-names></name>, <name name-style="western"><surname>Luxon</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kimmel</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>Mathematical model of NF-<italic>κ</italic>B regulatory module</article-title>. <source>J Theor Biol</source> <volume>228</volume>: <fpage>195</fpage>–<lpage>215</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lipniacki2"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Puszynski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brasier</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Kimmel</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>Single tnf <italic>α</italic> trimers mediating NF-<italic>κ</italic>B activation: stochastic robustness of NF-<italic>κ</italic>B signaling</article-title>. <source>BMC Bioinformatics</source> <volume>8</volume>: <fpage>376</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Boone1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boone</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Turer</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>MT</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses</article-title>. <source>Nat Immunol</source> <volume>5</volume>: <fpage>1052</fpage>–<lpage>1060</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Honma1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Honma</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsuzuki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nakagawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tagawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas</article-title>. <source>Blood</source> <volume>114</volume>: <fpage>2467</fpage>–<lpage>2475</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lin1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lacoste</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nakhaei</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Dissociation of a MAVS/IPS- 1/VISA/Cardif-IKK molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3–4A proteolytic cleavage</article-title>. <source>J Virol</source> <volume>80</volume>: <fpage>6072</fpage>–<lpage>6083</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Zhao1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Arguello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ballard</surname><given-names>DW</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>The NEMO adaptor bridges the nuclear factor-<italic>κ</italic>B and interferon regulatory factor signaling pathways</article-title>. <source>Nat Immunol</source> <volume>8</volume>: <fpage>592</fpage>–<lpage>600</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lin2"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nakhaei</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Sharif-Askari</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20</article-title>. <source>J Biol Chem</source> <volume>281</volume>: <fpage>2095</fpage>–<lpage>2103</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Nelson1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Ihekwaba</surname><given-names>AEC</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Gibney</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Oscillations in NF-<italic>κ</italic>B signaling control the dynamics of gene expression</article-title>. <source>Science</source> <volume>306</volume>: <fpage>704</fpage>–<lpage>708</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Tay1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hughey</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Quake</surname><given-names>SR</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Single-cell NF-<italic>κ</italic>B dynamics reveal digital activation and analogue information processing</article-title>. <source>Nature</source> <volume>466</volume>: <fpage>267</fpage>–<lpage>271</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lipniacki3"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brasier</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Luxon</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Kimmel</surname><given-names>M</given-names></name> (<year>2006</year>) <article-title>Stochastic regulation in early immune response</article-title>. <source>Biophys J</source> <volume>90</volume>: <fpage>725</fpage>–<lpage>742</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lipniacki4"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kimmel</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>Deterministic and stochastic models of NF-<italic>κ</italic>B pathway</article-title>. <source>Cardiovasc Toxicol</source> <volume>7</volume>: <fpage>215</fpage>–<lpage>234</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Barken1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barken</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Kearns</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Comment on “Oscillations in NF-<italic>κ</italic>B signaling control the dynamics of gene expression”</article-title>. <source>Science</source> <volume>308</volume>: <fpage>52</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Nelson2"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>See</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Response to comment on “Oscillations in NF-<italic>κ</italic>B signaling control the dynamics of gene expression”</article-title>. <source>Science</source> <volume>308</volume>: <fpage>52</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hat1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Puszynski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>Exploring mechanisms of oscillations in p53 and nuclear factor-<italic>κ</italic>B systems</article-title>. <source>IET Syst Biol</source> <volume>3</volume>: <fpage>342</fpage>–<lpage>355</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Beutler1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beutler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cerami</surname><given-names>A</given-names></name> (<year>1988</year>) <article-title>Tumor necrosis, cachexia, shock, and inflammation: a common mediator</article-title>. <source>Annu Rev Biochem</source> <volume>57</volume>: <fpage>505</fpage>–<lpage>518</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Aggarwal1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aggarwal</surname><given-names>BB</given-names></name> (<year>2003</year>) <article-title>Signalling pathways of the TNF superfamily: a double-edged sword</article-title>. <source>Nat Rev Immunol</source> <volume>3</volume>: <fpage>745</fpage>–<lpage>756</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Xaus1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xaus</surname><given-names>J</given-names></name>, <name name-style="western"><surname>ComaladaM, Valledor</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Lloberas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>López-Soriano</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-<italic>α</italic></article-title>. <source>Blood</source> <volume>95</volume>: <fpage>3823</fpage>–<lpage>3831</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Tracey1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tracey</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Fong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hesse</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Manogue</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>AT</given-names></name>, <etal>et al</etal>. (<year>1987</year>) <article-title>Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia</article-title>. <source>Nature</source> <volume>330</volume>: <fpage>662</fpage>–<lpage>664</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-Grell1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grell</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wajant</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zimmermann</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Scheurich</surname><given-names>P</given-names></name> (<year>1998</year>) <article-title>The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>95</volume>: <fpage>570</fpage>–<lpage>575</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Beg1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beg</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>1996</year>) <article-title>An essential role for nf-<italic>κ</italic>B in preventing TNF-<italic>α</italic>-induced cell death</article-title>. <source>Science</source> <volume>274</volume>: <fpage>782</fpage>–<lpage>784</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kelliher1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kelliher</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Grimm</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Stanger</surname><given-names>BZ</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>The death domain kinase RIP mediates the TNF-induced NF-<italic>κ</italic>B signal</article-title>. <source>Immunity</source> <volume>8</volume>: <fpage>297</fpage>–<lpage>303</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hsu1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Goeddel</surname><given-names>DV</given-names></name> (<year>1996</year>) <article-title>TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways</article-title>. <source>Cell</source> <volume>84</volume>: <fpage>299</fpage>–<lpage>308</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Collart1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Collart</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Baeuerle</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vassalli</surname><given-names>P</given-names></name> (<year>1990</year>) <article-title>Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four <italic>κ</italic>B-like motifs and of constitutive and inducible forms of NF-<italic>κ</italic>B</article-title>. <source>Mol Cell Biol</source> <volume>10</volume>: <fpage>1498</fpage>–<lpage>1506</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Udalova1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Udalova</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nedospasov</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Kwiatkowski</surname><given-names>D</given-names></name> (<year>1998</year>) <article-title>Complex NF-<italic>κ</italic>B interactions at the distal tumor necrosis factor promoter region in human monocytes</article-title>. <source>J Biol Chem</source> <volume>273</volume>: <fpage>21178</fpage>–<lpage>21186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Wu1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Boyer</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Whitaker</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Berchuck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wiener</surname><given-names>JR</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression</article-title>. <source>Cancer Res</source> <volume>53</volume>: <fpage>1939</fpage>–<lpage>1944</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Coward1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coward</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Okayama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sagara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Holgate</surname><given-names>ST</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>NF-<italic>κ</italic>B and TNF-<italic>α</italic>: a positive autocrine loop in human lung mast cells?</article-title> <source>J Immunol</source> <volume>169</volume>: <fpage>5287</fpage>–<lpage>5293</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-Guergnon1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guergnon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chaussepied</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sopp</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lizundia</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>MF</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>A tumour necrosis factor alpha autocrine loop contributes to proliferation and nuclear factor-<italic>κ</italic>B activation of Theileria parva-transformed B cells</article-title>. <source>Cell Microbiol</source> <volume>5</volume>: <fpage>709</fpage>–<lpage>716</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Nadeau1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nadeau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rivest</surname><given-names>S</given-names></name> (<year>2000</year>) <article-title>Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor <italic>κ</italic>B activity in the brain during endotoxemia</article-title>. <source>J Neurosci</source> <volume>20</volume>: <fpage>3456</fpage>–<lpage>3468</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kuno1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuno</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kawanokuchi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mizuno</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Autocrine activation of microglia by tumor necrosis factor-<italic>α</italic></article-title>. <source>J Neuroimmunol</source> <volume>162</volume>: <fpage>89</fpage>–<lpage>96</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hu1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Couvillon</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Exton</surname><given-names>JH</given-names></name> (<year>2006</year>) <article-title>Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1 <italic>α</italic>- mediated NF-<italic>κ</italic>B activation and down-regulation of TRAF2 expression</article-title>. <source>Mol Cell Biol</source> <volume>26</volume>: <fpage>3071</fpage>–<lpage>3084</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Rushworth1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rushworth</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>S</given-names></name>, <name name-style="western"><surname>MacEwan</surname><given-names>DJ</given-names></name> (<year>2011</year>) <article-title>TNF mediates the sustained activation of Nrf2 in human monocytes</article-title>. <source>J Immunol</source> <volume>187</volume>: <fpage>702</fpage>–<lpage>707</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hayakawa1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayakawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hiramatsu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kasai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Spontaneous activation of the NF-<italic>κ</italic>B signaling pathway in isolated normal glomeruli</article-title>. <source>Am J Physiol Renal Physiol</source> <volume>291</volume>: <fpage>F1169</fpage>–<lpage>F1176</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Tsai1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsai</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pesavento</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goldfeld</surname><given-names>AE</given-names></name> (<year>1996</year>) <article-title>Tumor necrosis factor <italic>α</italic> gene regulation in activated T cells involves ATF-2/Jun and NFATp</article-title>. <source>Mol Cell Biol</source> <volume>16</volume>: <fpage>459</fpage>–<lpage>467</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Liu1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sidiropoulos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pagliari</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Birrer</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>TNF-<italic>α</italic> gene expression in macrophages: regulation by NF-<italic>κ</italic>B is independent of c-Jun or C/EBP beta</article-title>. <source>J Immunol</source> <volume>164</volume>: <fpage>4277</fpage>–<lpage>4285</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Deleault1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deleault</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>SA</given-names></name> (<year>2008</year>) <article-title>Tristetraprolin regulates TNF TNF-<italic>α</italic> mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways</article-title>. <source>Mol Immunol</source> <volume>45</volume>: <fpage>13</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-Guma1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guma</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stepniak</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shaked</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Spehlmann</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Shenouda</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Constitutive intestinal NF-<italic>κ</italic>B does not trigger destructive inflammation unless accompanied by MAPK activation</article-title>. <source>J Exp Med</source> <volume>208</volume>: <fpage>1889</fpage>–<lpage>1900</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-Gais1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gais</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tiedje</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Altmayr</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gaestel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Weighardt</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>TRIF signaling stimulates translation of TNF-<italic>α</italic> mRNA via prolonged activation of MK2</article-title>. <source>J Immunol</source> <volume>184</volume>: <fpage>5842</fpage>–<lpage>5848</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Liacini1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liacini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sylvester</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WQ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Dehnade</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Induction of matrix metalloproteinase-13 gene expression by TNF-<italic>α</italic> is mediated by MAP kinases, AP-1, and NF-<italic>κ</italic>B transcription factors in articular chondrocytes</article-title>. <source>Exp Cell Res</source> <volume>288</volume>: <fpage>208</fpage>–<lpage>217</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Li1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>John</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Moylan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>TNF-<italic>α</italic> acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle</article-title>. <source>FASEB J</source> <volume>19</volume>: <fpage>362</fpage>–<lpage>370</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kawai1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S</given-names></name> (<year>2007</year>) <article-title>Signaling to NF-<italic>κ</italic>B by Toll-like receptors</article-title>. <source>Trends Mol Med</source> <volume>13</volume>: <fpage>460</fpage>–<lpage>469</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kawai2"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>Toll-like receptors and their crosstalk with other innate receptors in infection and immunity</article-title>. <source>Immunity</source> <volume>34</volume>: <fpage>637</fpage>–<lpage>650</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hao1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>2009</year>) <article-title>The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules</article-title>. <source>Nat Immunol</source> <volume>10</volume>: <fpage>281</fpage>–<lpage>288</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-Gutschow1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gutschow</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Hughey</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Ruggero</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bajar</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Valle</surname><given-names>SD</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Single-cell and population NF-<italic>κ</italic>B dynamic responses depend on lipopolysaccharide preparation</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e53222</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hiscott1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hiscott</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marois</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Garoufalis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>D’Addario</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roulston</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Characterization of a functional NF-<italic>κ</italic>B site in the human interleukin 1 <italic>β</italic> promoter: evidence for a positive autoregulatory loop</article-title>. <source>Molecular and Cellular Biology</source> <volume>13</volume>: <fpage>6231</fpage>–<lpage>6240</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Schooley1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">Schooley K, Zhu P, Dower SK, Qwarnstrm EE</collab> (<year>2003</year>) <article-title>Regulation of nuclear translocation of nuclear factor-<italic>κ</italic>B relA: evidence for complex dynamics at the single-cell level</article-title>. <source>Biochem J</source> <volume>369</volume>: <fpage>331</fpage>–<lpage>339</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Cheong1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheong</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Levchenko</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Understanding NF-<italic>κ</italic>B signaling via mathematical modeling</article-title>. <source>Mol Syst Biol</source> <volume>4</volume>: <fpage>192</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Terry1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Terry</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Chaplain</surname><given-names>MAJ</given-names></name> (<year>2011</year>) <article-title>Spatio-temporal modelling of the NF-<italic>κ</italic>B intracellular signalling pathway: the roles of diffusion, active transport, and cell geometry</article-title>. <source>J Theor Biol</source> <volume>290</volume>: <fpage>7</fpage>–<lpage>26</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Ashall1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashall</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>CV</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Pulsatile stimulation determines timing and specificity of NF-<italic>κ</italic>B-dependent transcription</article-title>. <source>Science</source> <volume>324</volume>: <fpage>242</fpage>–<lpage>246</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-James1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>James</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Moorman</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Carson</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Branda</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Lantz</surname><given-names>JW</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Nuclear translocation kinetics of NF-<italic>κ</italic>B in macrophages challenged with pathogens in a microfluidic platform</article-title>. <source>Biomed Microdevices</source> <volume>11</volume>: <fpage>693</fpage>–<lpage>700</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Turner1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Woodcock</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Physiological levels of TNF <italic>α</italic> stimulation induce stochastic dynamics of NF-<italic>κ</italic>B responses in single living cells</article-title>. <source>J Cell Sci</source> <volume>123</volume>: <fpage>2834</fpage>–<lpage>2843</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-gillespie1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname><given-names>DT</given-names></name> (<year>1977</year>) <article-title>Exact stochastic simulation of coupled chemical reactions</article-title>. <source>J Phys Chem</source> <volume>81</volume>: <fpage>2340</fpage>–<lpage>2361</lpage>.</mixed-citation>
</ref>
<ref id="pone-0078887-g0aeder1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Blinov</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Hlavacek</surname><given-names>WS</given-names></name> (<year>2009</year>) <article-title>Rule-based modeling of biochemical systems with BioNetGen</article-title>. <source>Methods Mol Biol</source> <volume>500</volume>: <fpage>113</fpage>–<lpage>167</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Barua1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barua</surname><given-names>D</given-names></name>, <name name-style="western"><surname>HlavacekWS, Lipniacki</surname><given-names>T</given-names></name> (<year>2012</year>) <article-title>A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn</article-title>. <source>J Immunol</source> <volume>189</volume>: <fpage>646</fpage>–<lpage>658</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lipniacki5"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Hlavacek</surname><given-names>WS</given-names></name> (<year>2008</year>) <article-title>Stochastic effects and bistability in T cell receptor signaling</article-title>. <source>J Theor Biol</source> <volume>254</volume>: <fpage>110</fpage>–<lpage>122</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Raj1"><label>80</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Peskin</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Tranchina</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vargas</surname><given-names>DY</given-names></name>, <name name-style="western"><surname>Tyagi</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>Stochastic mRNA synthesis in mammalian cells</article-title>. <source>PLoS Biol</source> <volume>4</volume>: <fpage>e309</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Haseltine1"><label>81</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haseltine</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Rawlings</surname><given-names>JB</given-names></name> (<year>2005</year>) <article-title>On the origins of approximations for stochastic chemical kinetics</article-title>. <source>J Chem Phys</source> <volume>123</volume>: <fpage>164115</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Werner1"><label>82</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Werner</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Barken</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Stimulus specificity of gene expression programs determined by temporal control of IKK activity</article-title>. <source>Science</source> <volume>309</volume>: <fpage>1857</fpage>–<lpage>1861</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Werner2"><label>83</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Werner</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Kearns</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Zadorozhnaya</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>O’Dea</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Encoding NF-<italic>κ</italic>B temporal control in response to TNF: distinct roles for the negative regulators I<italic>κ</italic>B<italic>α</italic> and A20</article-title>. <source>Genes Dev</source> <volume>22</volume>: <fpage>2093</fpage>–<lpage>2101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-McDonnell1"><label>84</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDonnell</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Abbott</surname><given-names>D</given-names></name> (<year>2009</year>) <article-title>What is stochastic resonance? Definitions, misconceptions, debates, and its relevance to biology</article-title>. <source>PLoS Comput Biol</source> <volume>5</volume>: <fpage>e1000348</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Vodovotz1"><label>85</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vodovotz</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Csete</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bartels</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>An</surname><given-names>G</given-names></name> (<year>2008</year>) <article-title>Translational systems biology of inflammation</article-title>. <source>PLoS Comput Biol</source> <volume>4</volume>: <fpage>e1000014</fpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Hymowitz1"><label>86</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hymowitz</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Wertz</surname><given-names>IE</given-names></name> (<year>2010</year>) <article-title>A20: from ubiquitin editing to tumour suppression</article-title>. <source>Nat Rev Cancer</source> <volume>10</volume>: <fpage>332</fpage>–<lpage>341</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Kato1"><label>87</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kato</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Takita</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Frequent inactivation of A20 in B-cell lymphomas</article-title>. <source>Nature</source> <volume>459</volume>: <fpage>712</fpage>–<lpage>716</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Dong1"><label>88</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chanudet</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Appert</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>YW</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma</article-title>. <source>Clin Cancer Res</source> <volume>17</volume>: <fpage>1440</fpage>–<lpage>1451</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Huang1"><label>89</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Mirtsos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chau</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Impaired TNF<italic>α</italic>-induced A20 expression in E1A/Ras-transformed cells</article-title>. <source>Br J Cancer</source> <volume>101</volume>: <fpage>1555</fpage>–<lpage>1564</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-JacksonBernitsas1"><label>90</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jackson-Bernitsas</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Ichikawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>XL</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-<italic>κ</italic>B activation and proliferation in human head and neck squamous cell carcinoma</article-title>. <source>Oncogene</source> <volume>26</volume>: <fpage>1385</fpage>–<lpage>1397</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lisby1"><label>91</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lisby</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Faurschou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gniadecki</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>The autocrine TNF<italic>α</italic> signalling loop in keratinocytes requires atypical PKC species and NF-<italic>κ</italic>B activation but is independent of cholesterol-enriched membrane microdomains</article-title>. <source>Biochem Pharmacol</source> <volume>73</volume>: <fpage>526</fpage>–<lpage>533</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Bian1"><label>92</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bian</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Opipari</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Ratanaproeksa</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Boitano</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>PC</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Constitutively active nf<italic>κ</italic>B is required for the survival of S-type neuroblastoma</article-title>. <source>J Biol Chem</source> <volume>277</volume>: <fpage>42144</fpage>–<lpage>42150</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Lombardo1"><label>93</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lombardo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Alvarez-Barrientos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maroto</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bosc</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Knaus</surname><given-names>UG</given-names></name> (<year>2007</year>) <article-title>TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-<italic>α</italic> autocrine signalling</article-title>. <source>J Immunol</source> <volume>178</volume>: <fpage>3731</fpage>–<lpage>3739</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Witsell1"><label>94</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witsell</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Schook</surname><given-names>LB</given-names></name> (<year>1992</year>) <article-title>Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>89</volume>: <fpage>4754</fpage>–<lpage>4758</lpage>.</mixed-citation>
</ref>
<ref id="pone.0078887-Parameswaran1"><label>95</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parameswaran</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Patial</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Tumor necrosis factor-<italic>α</italic> signaling in macrophages</article-title>. <source>Crit Rev Eukaryot Gene Expr</source> <volume>20</volume>: <fpage>87</fpage>–<lpage>103</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>